Increased Mortality and Health Risk Behaviors of Midlife White North Carolinians

作者
Christopher J. Mansfield,Katherine T. Jones,Satomi Imai
出处
期刊:North Carolina medical journal [North Carolina Medical Society Foundation's Community Practitioner Program]
卷期号:78 (6): 366-374 被引量:2
标识
DOI:10.18043/ncm.78.6.366
摘要

**Background:** The long-term efficacy and safety of mepolizumab in severe eosinophilic asthma (SEA) have been shown. **Aims:** To assess the impact of stopping versus continuing long-term mepolizumab on asthma worsening. **Methods:** COMET (NCT02555371) was a randomised, double-blind, placebo-controlled study. Patients had completed COLUMBA (NCT01691859) or COSMEX (NCT02135692), had continuous mepolizumab for ≥3 years (mean 46.6 months), and stayed on asthma controller therapy. Randomisation was 1:1 to stop (switch to placebo) or continue subcutaneous mepolizumab 100 mg for 52 weeks. Composite endpoint: time to first asthma worsening (defined in **Table**). Daily eDiary data were analysed using Kaplan--Meier estimates and a Cox proportional hazards model adjusted for covariates. **Results:** Treatment differences for those who stopped versus continued mepolizumab emerged by Week 4 (8 weeks post last open-label mepolizumab dose). For those who stopped mepolizumab, 51.7% reported asthma worsening by Week 52 versus 35.0% who continued mepolizumab (Table), leading to a significantly shorter time to first asthma worsening in those who stopped mepolizumab. **Conclusion:** Stopping mepolizumab in patients with SEA led to an increased risk of asthma worsening with a significantly shorter time to first asthma worsening versus those continuing long-term mepolizumab. **Funding:** GSK \[201810/NCT02555371\].

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被优零采纳,获得50
1秒前
传奇3的应助被豆豆豆豆采纳,获得10
1秒前
1秒前
徐丹枫发布了新的文献求助30
1秒前
彩虹完成签到,获得积分10
2秒前
tcb发布了新的文献求助40
2秒前
Kai发布了新的文献求助10
2秒前
2秒前
Duang发布了新的文献求助10
3秒前
3秒前
Akim的应助被热情煎饼采纳,获得10
3秒前
无花果的应助被大呲花采纳,获得10
3秒前
JerryPanJ发布了新的文献求助10
3秒前
烟花的应助被敏感寻真采纳,获得10
3秒前
黑犬完成签到,获得积分10
3秒前
3秒前
气不死你完成签到 ,获得积分10
3秒前
DDJ完成签到,获得积分10
4秒前
4秒前
笑点低的满天完成签到,获得积分10
4秒前
4秒前
蒋畅完成签到,获得积分20
4秒前
小马甲的应助被moonlight采纳,获得10
5秒前
5秒前
LB完成签到,获得积分10
5秒前
秋风的应助被安静的绿海采纳,获得20
5秒前
QQ发布了新的文献求助30
5秒前
6秒前
Cakoibao的应助被lizhen采纳,获得10
6秒前
7秒前
Owen的应助被QuanlongWang采纳,获得10
7秒前
soar发布了新的文献求助10
7秒前
7秒前
搜集达人的应助被shi采纳,获得10
7秒前
Zzzn完成签到 ,获得积分10
7秒前
害羞万天发布了新的文献求助10
7秒前
8秒前
初初初啊发布了新的文献求助10
8秒前
aajhajkahna的应助被nha采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170142
求助须知:如何正确求助?哪些是违规求助? 9563136
关于积分的说明 21768635
捐赠科研通 7761603
什么是DOI,文献DOI怎么找? 3430600
关于科研通互助平台的介绍 2554420
邀请新用户注册赠送积分活动 2475330